The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.

@article{Foltyn2012TheVO,
  title={The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.},
  author={Wanda Foltyn and Wojciech Zajęcki and Bogdan Marek and Dariusz Kajdaniuk and Lucyna Siemińśka and Anna Zemczak and Beata Kos-Kudła},
  journal={Endokrynologia Polska},
  year={2012},
  volume={63 5},
  pages={362-6}
}
INTRODUCTION Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are a heterogenous group of tumours of various clinical presentations. Proliferative activity of tumour cells is an essential parameter determining the course of the disease and affecting the prognosis. The Ki-67 antigen is an important marker of cell proliferation, which shows activity in all the phases of the cell cycle, excluding the G0 phase. AIM OF THE STUDY To assess the expression of Ki-67 in GEP NETs and to examine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Praktyczne zastosowanie klasyfikacji TNM z uwzględnieniem stopnia klinicznego zaawansowania choroby (staging) i stopnia histologicznej dojrzałości GEP NET (grading)

A. Nasierowska-Guttmejer
Guzy neroendokrynne układu pokarmowego. B. Kos-Kudła (red.), • 2010
View 1 Excerpt

Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2008
View 1 Excerpt

Similar Papers

Loading similar papers…